{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:28:39Z","timestamp":1791347319880,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1378\/chest.128.1.116","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T22:54:43Z","timestamp":1120776883000},"page":"116-123","source":"Crossref","is-referenced-by-count":207,"title":["Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection"],"prefix":"10.1016","volume":"128","author":[{"given":"Francis F.","family":"Fountain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary R.","family":"Chrisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.128.1.116_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.1953.63690010014007i","article-title":"Toxic hepatitis with jaundice occurring in a patient treated with isoniazid","volume":"152","author":"Randolph","year":"1953","journal-title":"JAMA"},{"key":"10.1378\/chest.128.1.116_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1961.63040230013013b","article-title":"Total hepatic necrosis secondary to isoniazid therapy","volume":"176","author":"Cohen","year":"1961","journal-title":"JAMA"},{"key":"10.1378\/chest.128.1.116_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid-associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.128.1.116_bib4","first-page":"991","article-title":"Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study","volume":"117","author":"Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.128.1.116_bib5","first-page":"65","article-title":"Hepatitis cases in isoniazid treated groups and in a control group","volume":"54","author":"Riska","year":"1979","journal-title":"Bull Int Union Tuberc"},{"key":"10.1378\/chest.128.1.116_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/ajrccm\/140.3.700","article-title":"Twenty isoniazid-associated deaths in one state","volume":"140","author":"Moulding","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.128.1.116_bib7","first-page":"151","article-title":"Isoniazid hepatitis among pregnant and postpartum Hispanic patients","volume":"104","author":"Franks","year":"1989","journal-title":"Public Health Rep"},{"key":"10.1378\/chest.128.1.116_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/ajrccm\/145.2_Pt_1.494","article-title":"Isoniazid-associated hepatitis deaths","volume":"145","author":"Snider","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.128.1.116_bib9","first-page":"486","article-title":"Isoniazid-related fatal hepatitis","volume":"164","author":"Millard","year":"1996","journal-title":"West J Med"},{"key":"10.1378\/chest.128.1.116_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a Public Health Tuberculosis Clinic","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"10.1378\/chest.128.1.116_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","author":"ATS\/CDC\/IDSA joint statement","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.128.1.116_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.128.1.116_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-137-8-200210150-00007","article-title":"Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial","volume":"137","author":"Jasmer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.128.1.116_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1378\/chest.123.1.102","article-title":"Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis","volume":"123","author":"McNeill","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.128.1.116_bib15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1164\/ajrccm.162.5.2003028","article-title":"Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis","volume":"162","author":"Jasmer","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.128.1.116_bib16","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV infected persons","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.128.1.116_bib17","first-page":"735","article-title":"Update adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for the treatment of latent tuberculosis infection","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.128.1.116_bib18","first-page":"686","article-title":"Acetylating of acetylhydrazine, the toxic metabolite of isoniazid, in humans: inhibition by concomitant administration of isoniazid","volume":"243","author":"Peretti","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.128.1.116_bib19","first-page":"699","article-title":"CYP2E1 mediated isoniazid-induced hepatotoxicity in rats","volume":"25","author":"Yue","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1378\/chest.128.1.116_bib20","first-page":"5221","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"Official Statement of the American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.128.1.116_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.1977.03630210016007","article-title":"Isoniazid chemoprophylaxis: association with detection and incidence of liver toxicity","volume":"137","author":"Byrd","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.128.1.116_bib22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7326\/0003-4819-71-6-1113","article-title":"Serum transaminase elevations and their hepatic abnormalities in patients receiving isoniazid","volume":"71","author":"Scharer","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.128.1.116_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/arrd.1973.107.4.523","article-title":"Disturbed hepatic function during isoniazid chemprophylaxis","volume":"107","author":"Bailey","year":"1973","journal-title":"Am Rev Respir Dis"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215379356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215379356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T05:44:25Z","timestamp":1586324665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215379356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0012369215379356"],"URL":"https:\/\/doi.org\/10.1378\/chest.128.1.116","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}